Strategic consulting in preclinical and clinical drug development with emphasis on biomarker-based risk assessment, novel biomarker translational research, pharmaceutical services business development and strategies for the development of companion diagno
Targos core biomarker service business is to provide highly standardized development and application of clinical biomarkers for the international pharmaceutical and diagnostic industry.
Targos core biomarker service business is to provide highly standardized development and application of clinical biomarkers for the international pharmaceutical and diagnostic industry.
Targos core biomarker service business is to provide highly standardized development and application of clinical biomarkers for the international pharmaceutical and diagnostic industry.
Targos core biomarker service business is to provide highly standardized development and application of clinical biomarkers for the international pharmaceutical and diagnostic industry.
Targos core biomarker service business is to provide highly standardized development and application of clinical biomarkers for the international pharmaceutical and diagnostic industry.
Targos core biomarker service business is to provide highly standardized development and application of clinical biomarkers for the international pharmaceutical and diagnostic industry.
ACD’s RNAscope® is the first multiplex in situ hybridization platform for single RNA molecule detection, with applications in biomarker validation, companion diagnostics and molecular pathology. It addresses the issue of patient and disease heterogeneity
The Center for Biomarker Discovery and Translation is a division of the Pathology Department at The Johns Hopkins University School of Medicine in Baltimore, Ma
Strategic consulting in preclinical and clinical drug development with emphasis on biomarker-based risk assessment, novel biomarker translational research, pharmaceutical services business development and strategies for the development of companion diagno
Reveal Biosciences is a CRO specializing in advanced tissue technologies. We help our clients contain costs, meet timelines and achieve their research goals
Reveal Biosciences is a CRO specializing in advanced tissue technologies. We help our clients contain costs, meet timelines and achieve their research goals
Reveal Biosciences is a CRO specializing in advanced tissue technologies. We help our clients contain costs, meet timelines and achieve their research goals
Synelvia is an independent innovating Contract Research Organization dedicated to the evaluation of drug efficacy in cosmetology, dermatology, cardio-metabolic, drug development & nutraceuticals
Targos core biomarker service business is to provide highly standardized development and application of clinical biomarkers for the international pharmaceutical and diagnostic industry.